Skip to main content
. 2024 Mar 3;14:5201. doi: 10.1038/s41598-024-55865-1

Table 2.

Drug resistance mutations identified in the 59 M. tuberculosis isolates.

Drug Gene Mutation** Our study N Our study % Other Thailand % Global %
(/59) (n = 1456)*** (n = 50k)****
Isoniazid fabG1 -15C>T 5 8.4 6.1 25.0
Isoniazid katG Ser315Thr 9 15.3 56.9 78.6
Isoniazid katG 1002_1003dupGA 1 1.7 0.1 0.0
Rifampicin rpoB Ser450Trp 2 3.4 0.8 1.1
Rifampicin rpoB His445Tyr 2 3.4 7.5 3.3
Rifampicin rpoB Ser450Leu 3 5.1 35.6 57.7
Ethionamide ethA Thr232Ala 5 8.4 0.5 0.0
Ethionamide fabG1 -15C>T 5 8.4 6.1 25.0
Ethambutol embA -16C>T 1 1.7 0.8 2.4
Ethambutol embB Arg507Lys 1 1.7 0.1 0.0
Ethambutol embB Met306Leu 1 1.7 1.0 1.2
Pyrazinamide pncA Ser104Arg 5 8.4 0.7 0.5
Pyrazinamide pncA Thr142Lys 1 1.7 0.2 0.1
Ciprofloxacin gyrA Asp94Gly 1 1.7 5.1 11.7
Ciprofloxacin gyrB Asp494Ala 1 1.7 0.6 0.0
Fluoroquinolones gyrA Asp94Gly 1 1.7 5.1 11.7
Fluoroquinolones gyrB Asp494Ala 1 1.7 0.6 0.0
PAS thyX -16C>T 1 1.7 2.5 2.4
Streptomycin gid Glu92* 1 1.7 0.1 0.1
Streptomycin gid 351delG 1 1.7 1.0 1.8
Streptomycin gid 351dupG 1 1.7 0.3 0.4
Streptomycin rpsL Lys43Arg 3 5.1 37.6 38.9
Streptomycin rpsL Lys88Arg 2 3.4 3.6 9.9
Streptomycin rrs 514A>C 2 3 1.6 7.3
Streptomycin rrs 517C>T 1 1.7 0.8 4.6

*stop codon; **supported by Oxford Nanopore Technology (ONT) (whole genome) and Illumina sequencing; PAS para-aminosalicylic acid; ***from2,6; ****from2.